• BX

Blackstone's profit surges as dealmaking rebounds, execs signal CRE recovery

• BLK
• BX
• SCBFF
• V

China's Vice Premier lunches with Dimon, Schwarzman and other Davos financiers

Chinese Vice Premier Ding Xuexiang met global finance leaders at Davos, discussing investment and economic stimulus amid U.S.-China relations and slowing Chinese growth.

• 4183
• BX

Mitsubishi Chemical picks Bain as preferred bidder for subsidiary, Nikkei says

Mitsubishi Chemical selects Bain Capital as preferred bidder for Tanabe Mitsubishi Pharma, expected sale price over $3.2 billion.

• AMZN
• BX
• FMG
• META
• MSFT

Goodman Group shines among Australian property firms on data-centre push

Goodman Group's stock has surged 45.8% this year amid increasing AI-driven demand for data centers, outpacing peers and raising both optimism and caution among investors.

• ANSS
• BARC
• BX
• COF
• JPM
• MS
• SNPS

Dealmakers eye $4 trillion-plus M&A haul in 2025 on Trump boost

Bankers predict global M&A activity to exceed $4 trillion in 2024, fueled by expected deregulation and a favorable economic climate under Trump's administration.

• APO
• BX

Federal Reserve rate cut seen as positive for private equity market

• BX
• CZR
• DBKGn
• WING

Bain Capital in talks to buy Little Caesars operator Sizzling Platter, sources say

Bain Capital is negotiating to acquire Sizzling Platter for over $1 billion, including debt, amid a broader trend of private equity interest in restaurant franchises.

• BP
• BX
• NG

BP, ADNOC's XRG agree Egypt gas JV Arcius Energy

BP and ADNOC's XRG have launched Arcius Energy, a natural gas joint venture in Egypt, enhancing their international operations and focusing on low-carbon energy investments.

• BX

Blackstone, Bain to bid for Mitsubishi pharma unit in up to $3.5 billion deal, sources say

Blackstone and Bain Capital are bidding for Mitsubishi Tanabe Pharma, valued at up to $3.5 billion, as part of Mitsubishi Chemical's divestiture strategy.

• ABBV
• BHC
• BX

Contact lens maker Bausch + Lomb says it is exploring sale

Bausch + Lomb is considering a sale to aid parent Bausch Health's exit, amid private equity interest, following share volatility and earlier reports of a potential bid.